Is BIO or TMDX cheaper?

On trailing earnings, TMDX is cheaper: BIO trades at a 46.53 P/E and TMDX at 18.03.

Which has grown faster, BIO or TMDX?

Over the past five years, TMDX grew revenue faster — BIO at a -0.84% CAGR versus TMDX at 90.79%.

Is BIO or TMDX more profitable?

TMDX runs the higher net margin — BIO at 6.52% versus TMDX at 27.04%.

Which has been the better investment, BIO or TMDX?

Over the past 5-year, TMDX delivered the higher annualized total return — BIO at 7.20% versus TMDX at 21.48%. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs TransMedics Group, Inc. (TMDX)

TMDX leads on 9 of 13 compared metrics.

A side-by-side comparison of Bio-Rad Laboratories, Inc. and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 20, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BIO

Bio-Rad Laboratories, Inc.

$7.64B

$282.44Healthcare

TMDX

TransMedics Group, Inc.

$2.72B

$78.79Healthcare

Total return — BIO vs TMDX

growth of $100 · last 7y

BIO -6.5%TMDX +252.4%TMDX compounded faster

BIO TMDX

BIO vs TMDX: by the numbers

•BIO is the larger company ($7.64B vs $2.72B market cap).
•TMDX trades at the lower earnings multiple (18.03 vs 46.53 P/E).
•TMDX converts more revenue to profit (27.04% vs 6.52% net margin).
•TMDX grew revenue faster over the past five years (90.79% vs -0.84% CAGR).

Which is better, BIO or TMDX?

Metric tally: BIO 4 · TMDX 9

It depends on what you're optimizing for:

ValueTMDX(lower P/E)

GrowthTMDX(faster 5Y revenue CAGR)

QualityTMDX(higher ROIC)

Metrics side by side

Valuation

Metric	BIO	TMDX
P/E ratio	46.53	18.03●
Forward P/E	28.34●	38.89
P/S ratio	2.94●	4.48
P/B ratio	1.11●	5.77
PEG ratio	—	0.05
EV / EBITDA	18.06●	23.28
FCF yield	4.69%	5.31%●

Profitability

Metric	BIO	TMDX
Gross margin	51.87%	59.09%●
Operating margin	9.25%	14.85%●
Net margin	6.52%	27.04%●
ROE	2.46%	34.80%●
ROIC	2.04%	10.94%●

Growth (annualized)

Metric	BIO	TMDX
Revenue CAGR (5Y)	-0.84%	90.79%●
EPS CAGR (5Y)	-26.27%	—
FCF CAGR (5Y)	-7.57%	—
Total return CAGR (5Y)	-14.63%	21.48%●

Frequently asked

Which is better, BIO or TMDX?: It depends on your goal. value: TMDX (lower P/E); growth: TMDX (faster 5Y revenue CAGR); quality: TMDX (higher ROIC). Across all compared metrics, TMDX leads 9 to 4.
Is BIO or TMDX cheaper?: On trailing earnings, TMDX is cheaper: BIO trades at a 46.53 P/E and TMDX at 18.03.
Which has grown faster, BIO or TMDX?: Over the past five years, TMDX grew revenue faster — BIO at a -0.84% CAGR versus TMDX at 90.79%.
Is BIO or TMDX more profitable?: TMDX runs the higher net margin — BIO at 6.52% versus TMDX at 27.04%.
Which has been the better investment, BIO or TMDX?: Over the past 5-year, TMDX delivered the higher annualized total return — BIO at 7.20% versus TMDX at 21.48%. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full TMDX analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio TransMedics P/E ratio Bio-Rad Laboratories dividend yield TransMedics dividend yield Bio-Rad Laboratories ROE TransMedics ROE Bio-Rad Laboratories operating margin TransMedics operating margin Bio-Rad Laboratories revenue growth TransMedics revenue growth Bio-Rad Laboratories free cash flow TransMedics free cash flow

Bio-Rad Laboratories & TransMedics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 20, 2026.